The most defined therapeutic molecular classification of breast cancer is based on the status of oestrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 [4–6]. This evidence concerns the gene PGR and breast carcinoma.